News

PAN-PROVINCIAL VACCINE ENTERPRISE INC. (PREVENT) announces a license to develop a seasonal influenza vaccine

Saskatoon, SK – April 09, 2013 - The Pan-Provincial Vaccine Enterprise Inc. (PREVENT), a national Centre of Excellence for Commercialization and...

Pan-Provincial Vaccine Enterprise and the Vaccine and Infectious Disease Organization – International Vaccine Centre sign collaborative vaccine development agreement with South China United Vaccine Institute and Guangzhou Institute of Respiratory Disease

Guangzhou, China – The Pan-Provincial Vaccine Enterprise (PREVENT), a national Centre of Excellence for Commercialization and Research (CECR), a...

Government Invest $3.4 Million Into Livestock Research

Research Funding to Help Grow the Industry and Benefit Livestock and Forage Producers Today federal Agriculture Minister Gerry Ritz and Saskatchewa...

PAN-PROVINCIAL VACCINE ENTERPRISE INC. (PREVENT) announces a license to refine a vaccine against Chlamydia infection

Saskatoon, SK – August 27, 2012 - The Pan-Provincial Vaccine Enterprise Inc. (PREVENT), a national Centre of Excellence for Commercialization an...

PAN-PROVINCIAL VACCINE ENTERPRISE INC. (PREVENT) DEVELOPING Group A Streptococcus (GAS) VACCINE

Saskatoon, SK – August 2, 2011 – The Pan-Provincial Vaccine Enterprise Inc. (PREVENT), a Centre of Excellence for Commercialization and Re...

PAN-PROVINCIAL VACCINE ENTERPRISE INC. (PREVENT) DEVELOPING Respiratory Syncytial Virus (RSV) VACCINE

Saskatoon, SK – September 1, 2010 – The Pan-Provincial Vaccine Enterprise Inc. (PREVENT), a national Centre of Excellence for Commercializ...

PAN-PROVINCIAL VACCINE ENTERPRISE INC. (PREVENT) DEVELOPING AMYOTROPHIC LATERAL SCLEROSIS (ALS) VACCINE

Saskatoon, SK – June 16, 2010 – The Pan-Provincial Vaccine Enterprise Inc. (PREVENT), a national Centre of Excellence for Commercializatio...

PAN-PROVINCIAL VACCINE ENTERPRISE INC.(PREVENT) DEVELOPING CHRONIC WASTING DISEASE (CWD) VACCINE

Saskatoon, SK - May 19, 2010 - The Pan-Provincial Vaccine Enterprise Inc. (PREVENT), has reached an agreement with the Vaccine and Infectious Diseas...